tiprankstipranks
Top 3 Trending Stocks, According to Analysts – 12/25/2024  
PremiumMarket NewsTop 3 Trending Stocks, According to Analysts – 12/25/2024  
24d ago
Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist
26d ago
Vertex Pharmaceuticals price target raised to $430 from $426 at Scotiabank
Premium
The Fly
Vertex Pharmaceuticals price target raised to $430 from $426 at Scotiabank
26d ago
Vertex announces FDA exands approval for Trikafta
PremiumThe FlyVertex announces FDA exands approval for Trikafta
29d ago
Channel Therapeutics highlights difference between NaV1.7, NaV1.8
Premium
The Fly
Channel Therapeutics highlights difference between NaV1.7, NaV1.8
29d ago
Vertex Pharmaceuticals price target lowered to $520 from $566 at BMO Capital
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $520 from $566 at BMO Capital
29d ago
Oppenheimer downgrades Vertex after lumbosacral radiculopathy study
PremiumThe FlyOppenheimer downgrades Vertex after lumbosacral radiculopathy study
30d ago
Vertex Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Vertex Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
30d ago
Vertex Pharmaceuticals price target lowered to $400 from $451 at RBC Capital
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $400 from $451 at RBC Capital
30d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100